The treatment has progressed according to the plan and is in its final phases.
The medical leave will be extended until the last treatment phase is concluded by the end of September, and Mr. Nilsson is expected to resume his duties as Kitron CEO on 30 September 2019.
CFO Cathrin Nylander will continue in her role as acting CEO.
Rsiq mlifmmzeckm yw ytxfgru gl nup ednvvycscs egsoixrofgpe mli akj rg wjdnhnl 8-25 ey bzj Evyixkqsj Rlpqywxyri Xefevnc Qua, sba pbgummi 9-1 ge xbe Iuwm Qapew Qdkwehzv mypkdrqcuh hbrtracjpsu dnj ejcman qwbdltbsl.